- About this Journal ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 763159, 6 pages
Pharmacotherapy in Pediatric Neurogenic Bladder Intravesical Botulinum Toxin Type A
Urology Department, Hospital de Pediatría S.A.M.I.C. “Prof. Dr. Juan P. Garrahan”, Combate de los Pozos No. 1881 (CPA: C 1245 AAM), Buenos Aires, Argentina
Received 7 March 2012; Accepted 5 April 2012
Academic Editors: D. Minardi and J. Walter
Copyright © 2012 Cristian Sager et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- E. J. McGuire, J. R. Woodside, T. A. Borden, and R. M. Weiss, “Prognostic value of urodynamic testing in myelodysplastic patients,” Journal of Urology, vol. 126, no. 2, pp. 205–209, 1981.
- S. B. Bauer, M. Hallet, S. Khosbin, et al., “Predictive value of urodinamic evaluation in newborns with myelodysplasia,” Journal of the American Medical Association, vol. 252, no. 5, pp. 650–652, 1984.
- R. D. Hernandez, R. S. Hurwitz, J. E. Foote, P. E. Zimmern, and G. E. Leach, “Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele,” Journal of Urology, vol. 152, no. 5 I, pp. 1582–1585, 1994.
- P. Abrams, G. Larsson, C. Chapple, and A. J. Wein, “Factors involved in the success of antimuscarinic treatment,” International British Journal of Urology, vol. 83, supplement 2, pp. 42–47, 1999.
- D. D. Dykstra and A. A. Sidi, “Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study,” Archives of Physical Medicine and Rehabilitation, vol. 71, no. 1, pp. 24–26, 1990.
- M. Stohrer, B. Schuch, G. Kramer, D. Schmidt, D. Gaul, and D. Hauri, “Botulinum A toxin in the treatment of detrusor hyperreflexia in spinal cord injury. A new alternative to medical and surgical procedures?” Neurourology and Urodynamics, vol. 18, pp. 401–402, 1999.
- H. Schulte-Baukloh, T. Michael, J. Schobert, T. Stolze, and H. H. Knispel, “Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results,” Urology, vol. 59, no. 3, pp. 325–327, 2002.
- N. Yoshimura, “Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder,” Progress in Neurobiology, vol. 57, no. 6, pp. 583–606, 1999.
- R. J. Valentino, S. K. Wood, A. J. Wein, and S. A. Zderic, “The bladder-brain connection: Putative role of corticotropin-releasing factor,” Nature Reviews Urology, vol. 8, no. 1, pp. 19–28, 2011.
- A. Apostolidis and C. J. Fowler, “The use of botulinum neurotoxin type A (BoNTA) in urology,” Journal of Neural Transmission, vol. 115, no. 4, pp. 593–605, 2008.
- O. Dolly, “Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins,” Headache, vol. 43, supplement 1, pp. S16–S24, 2003.
- A. Apostolidis, P. Dasgupta, and C. J. Fowler, “Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity,” European Urology, vol. 49, no. 4, pp. 644–650, 2006.
- M. Riccabona, M. Koen, M. Schindler, B. Goedele, A. Pycha, and L. Lusuardi, “Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia,” Journal of Urology, vol. 171, no. 2 I, pp. 845–848, 2004.
- H. Schulte-Baukloh, T. Michael, B. Sturzebecher, and H. H. Knispel, “Botulinum-A toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder,” European Urology, vol. 44, no. 1, pp. 139–143, 2003.
- H. Schulte-Baukloh, H. H. Knispel, T. Stolze, C. Weiss, T. Michael, and K. Miller, “Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity,” Urology, vol. 66, no. 4, pp. 865–870, 2005.
- A. M. Kajbafzadeh, S. Moosavi, P. Tajik et al., “Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele,” Urology, vol. 68, no. 5, pp. 1091–1096, 2006.
- C. Sager, C. Burek, V. Duran, et al., “Toxina botulínica-A en el tratamiento de niños con vejiga neurogénica,” Cirugia Pediatrica, vol. 24, pp. 38–43, 2011.
- A. Apostolidis, P. Dasgupta, P. Denys et al., “Recommendations on the use of botulinum toxin in treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report,” European Urology, vol. 55, no. 1, pp. 100–120, 2009.
- S. H. Allousi, Ch. Lang, R. Eichel, et al., “Videourodynamic changes of botulinum toxin A in patients with neurogenic bladderdysfunction (NBD) and idiopathic detrusor hyperactivity (IDO) refractory to drug treatment,” World Journal of Urology, vol. 30, no. 3, pp. 367–373, 2012.
- M. P. Pascali, G. Mosiello, R. Boldrini, M. L. Salsano, E. Castelli, and M. de Gennaro, “Effects of botulinum toxin type A in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections,” Journal of Urology, vol. 185, no. 6, pp. 2552–2557, 2011.
- M. P. Pascali, G. Mosiello, A. Marciano, M. L. Capitanucci, A. M. Zaccara, and M. De Gennaro, “A simplified technique for botulinum toxin injections in children with neurogenic bladder,” Journal of Urology, vol. 185, no. 6, pp. 2558–2562, 2011.
- A. M. Kajbafzadeh, L. Nikfarjam, A. H. Mahboubi, and S. Dianat, “Antibody formation following botulinum toxin type A ( dysport ) injection in children with intractable bladder hyperreflexia,” Urology, vol. 76, no. 1, pp. 233–237, 2010.
- A. V. Deshpande, R. Sampang, and G. H. H. Smith, “Study of botulinum toxin A in neurogenic bladder due to spina bifida in children,” ANZ Journal of Surgery, vol. 80, no. 4, pp. 250–253, 2010.
- G. Hirst, K. Wareham, S. Emery, et al., “Failure of botulinum toxin type B in the treatment of the refractory overactive bladder,” in Proceedings of the International Continence Society Annual Meeting, Montreal, Canada, August 2005, Abstrac no. 432.
- J. Grosse, G. Kramer, and M. Stohrer, “Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence,” European Urology, vol. 47, no. 5, pp. 653–659, 2005.
- W. Altaweel, R. Jednack, C. Bilodeau, and J. Corcos, “Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele,” Journal of Urology, vol. 175, no. 3, pp. 1102–1105, 2006.
- E. Shapiro, M. J. Becich, E. Perlman, and H. Lepor, “Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis,” Journal of Urology, vol. 145, no. 5, pp. 1024–1029, 1991.
- A. Haferkamp, J. Dorsam, N. M. Resnick, S. V. Yalla, and A. Elbadawi, “Structural basis of neurogenic bladder dysfunction. II. Myogenic basis of detrusor hyperreflexia,” Journal of Urology, vol. 169, no. 2, pp. 547–554, 2003.
- M. Akbar, R. Abel, T. M. Seyler, H. J. Gerner, and K. Möhring, “Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction,” International British Journal of Urology, vol. 100, no. 3, pp. 639–645, 2007.
- S. K. Sharma, J. L. Ferreira, B. S. Eblen, and R. C. Whiting, “Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies,” Applied and Environmental Microbiology, vol. 72, no. 2, pp. 1231–1238, 2006.
- K. de Laet and J. J. Wyndaele, “Adverse events after botulinum A toxin injection for neurogenic voiding disorders,” Spinal Cord, vol. 43, no. 7, pp. 397–399, 2005.
- T. M. Kessler, H. Danuser, M. Schumacher, U. E. Studer, and F. C. Burkhard, “Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?” Neurourology and Urodynamics, vol. 24, no. 3, pp. 231–236, 2005.